Literature DB >> 9472898

Subtractive cloning identifies tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) increased gene expression following focal stroke.

X Wang1, F C Barone, R F White, G Z Feuerstein.   

Abstract

BACKGROUND AND
PURPOSE: Differential gene expression has been reported following the onset of focal stroke. To identify de novo expression of ischemia-induced genes, we applied subtractive cDNA library strategy to identify the genes that are selectively upregulated by focal stroke.
METHODS: Spontaneously hypertensive rats were subjected to permanent occlusion of the middle cerebral artery (MCAO). mRNAs prepared from ischemic and nonischemic cortex 2 and 12 hours after MCAO were subtracted, and a subtractive cDNA library was constructed. A cDNA that encodes for tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) was identified in the subtractive cDNA library. The temporal expression of cortical TIMP-1 mRNA was further characterized in ischemic cortex subjected to permanent or temporary (160-minute) MCAO.
RESULTS: A panel of genes isolated from the subtractive cDNA library was subjected to Southern analysis to confirm ischemia-induced gene expression. TIMP-1 demonstrated robust induction after ischemic injury. Time-course studies revealed that TIMP-1 mRNA was induced threefold over controls at 12 hours (P<.001, n=4 animals) and reached a peak level at 2 days after permanent MCAO (sevenfold increase, P<.001). Similar induction profile of TIMP-1 mRNA was observed in the ischemic cortex after temporary MCAO followed by reperfusion.
CONCLUSIONS: This work demonstrated the utility of subtractive cDNA library strategy for discovery of genes differentially expressed in focal stroke. Furthermore, our data implicate TIMP-1 in ischemia-induced brain injury.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9472898     DOI: 10.1161/01.str.29.2.516

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  6 in total

1.  Thrombopoietin protects the brain and improves sensorimotor functions: reduction of stroke-induced MMP-9 upregulation and blood-brain barrier injury.

Authors:  Jin Zhou; Jie Li; Daniel M Rosenbaum; Frank C Barone
Journal:  J Cereb Blood Flow Metab       Date:  2010-09-29       Impact factor: 6.200

2.  Resveratrol attenuates the blood-brain barrier dysfunction by regulation of the MMP-9/TIMP-1 balance after cerebral ischemia reperfusion in rats.

Authors:  Haidong Wei; Shiquan Wang; Luming Zhen; Qianzi Yang; Zhixin Wu; Xiaoming Lei; Jianrui Lv; Lize Xiong; Rongliang Xue
Journal:  J Mol Neurosci       Date:  2014-10-21       Impact factor: 3.444

3.  A lipoxin A4 analog ameliorates blood-brain barrier dysfunction and reduces MMP-9 expression in a rat model of focal cerebral ischemia-reperfusion injury.

Authors:  Yan Wu; Yan-Ping Wang; Peipei Guo; Xi-Hong Ye; Jie Wang; Shi-Ying Yuan; Shang-Long Yao; You Shang
Journal:  J Mol Neurosci       Date:  2011-08-16       Impact factor: 3.444

4.  Skull Fractures Induce Neuroinflammation and Worsen Outcomes after Closed Head Injury in Mice.

Authors:  Liga Zvejniece; Gundega Stelfa; Edijs Vavers; Einars Kupats; Janis Kuka; Baiba Svalbe; Baiba Zvejniece; Christiane Albert-Weissenberger; Anna-Leena Sirén; Nikolaus Plesnila; Maija Dambrova
Journal:  J Neurotrauma       Date:  2019-11-08       Impact factor: 5.269

Review 5.  Integrated Analysis of Expression Profile Based on Differentially Expressed Genes in Middle Cerebral Artery Occlusion Animal Models.

Authors:  Huaqiang Zhou; Zeting Qiu; Shaowei Gao; Qinchang Chen; Si Li; Wulin Tan; Xiaochen Liu; Zhongxing Wang
Journal:  Int J Mol Sci       Date:  2016-05-20       Impact factor: 5.923

6.  Polymerase delta-interacting protein 2 deficiency protects against blood-brain barrier permeability in the ischemic brain.

Authors:  Marina S Hernandes; Bernard Lassègue; Lula L Hilenski; Jonathan Adams; Ning Gao; Chia-Yi Kuan; Yu-Yo Sun; Lihong Cheng; Daniel S Kikuchi; Manuel Yepes; Kathy K Griendling
Journal:  J Neuroinflammation       Date:  2018-02-17       Impact factor: 8.322

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.